Evidence map›Paper›PMID 38464758›Full record

ArticlePeerJ2024

Serum immunoglobulin M is associated with the severity of coronary artery disease in adults.

Yanan Zhang, Xi Qi, Siming Wang, Wenduo Zhang, Ruiyue Yang, Xinyue Wang, Wenxiang Chen, Fusui Ji, Jun Dong, Xue Yu

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanan Zhang *The Affiliated Hospital of Qingdao University, Qing Dao, Shan Dong, China.
Xi Qi *Beijing Hospital, Beijing, China.
Siming WangBeijing Hospital, Beijing, China.
Wenduo ZhangBeijing Hospital, Beijing, China.
Ruiyue YangBeijing Hospital, Beijing, China.ORCID 0000-0002-2304-6728
Xinyue WangBeijing Hospital, Beijing, China.
Wenxiang ChenBeijing Hospital, Beijing, China.
Fusui JiBeijing Hospital, Beijing, China.
Jun DongBeijing Hospital, Beijing, China.
Xue YuBeijing Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to investigate the relationship between serum immunoglobulin M (IgM) and the severity of coronary artery disease in Chinese patients who underwent coronary angiography. Methods: A total of 2,045 patients who underwent coronary angiography (CAG) from March 2017 to March 2020 at Beijing Hospital were included in this study. Serum IgM concentration and biochemical indicators were measured before coronary angiography (CAG). The triquartile IgM levels at baseline in the population were analysed. Spearman rank correlation was used to analyse the association between IgM and traditional risk factors for coronary artery disease (CAD). CAD patients were divided into subgroups by affected area, number of affected vessels, and Gensini score to analyse the relationship between IgM and CAD severity. Multivariable logistic regression analysis was used to evaluate the association between IgM and CAD severity. Results: Serum IgM levels were significantly lower in the CAD group (63.5 mg/dL) than in the non-coronary artery disease (NCAD) group (72.3 mg/dL) ( Conclusion: We determined that serum IgM was independently negatively associated with the severity of CAD diagnosed by angiography in Chinese adults.

Indexed as

Coronary Artery DiseaseHypertensionAdultCoronary AngiographyHumansImmunoglobulin MRisk FactorsImmunoglobulin MAtherosclerosisCoronary angiographyCoronary artery diseaseGensini scoreSerum immunoglobulin M

Identifiers

PMID38464758
PMCPMC10921929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.